Abstract
Recycling old drugs, rescuing shelved drugs and extending patents' lives make drug repositioning an attractive form of drug discovery. Drug repositioning accounts for approximately 30% of the newly US Food and Drug Administration (FDA)-approved drugs and vaccines in recent years. The prevalence of drug-repositioning studies has resulted in a variety of innovative computational methods for the identification of new opportunities for the use of old drugs. Questions often arise from customizing or optimizing these methods into efficient drug-repositioning pipelines for alternative applications. It requires a comprehensive understanding of the available methods gained by evaluating both biological and pharmaceutical knowledge and the elucidated mechanism-of-action of drugs. Here, we provide guidance for prioritizing and integrating drug-repositioning methods for specific drug-repositioning pipelines.
Original language | English (US) |
---|---|
Pages (from-to) | 637-644 |
Number of pages | 8 |
Journal | Drug Discovery Today |
Volume | 19 |
Issue number | 5 |
DOIs | |
State | Published - May 2014 |
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery